INSTITUT-BIOTHERAPIES

Company in France

Share this profile

Resume
Myotubular Myopathy : Genethon welcomes interim data of a phase I / II clinical trial with a gene therapy product developed in its laboratories > Institut Des Biothérapies

  last updated on October 17th, 2024